Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$104.48
+2.82%
Mkt Cap $4.41B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (20 analysts)
$115.00
Range $55.00 – $145.00
Implied Upside
+10.1%
Consensus $115.00 vs current $104.48